Log in to save to my catalogue

CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurod...

CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurod...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1fe5940f23884dd28924de1e2c522e1d

CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Progranulin (PGRN) is predominantly expressed by microglia in the brain, and genetic and experimental evidence suggests a critical role in Alzheimer's disease (AD). We asked whether PGRN expression is changed in a disease severity‐specific manner in AD. We measured PGRN in cerebrospinal fluid (CSF) in two of the best‐characterized AD patient cohort...

Alternative Titles

Full title

CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1fe5940f23884dd28924de1e2c522e1d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1fe5940f23884dd28924de1e2c522e1d

Other Identifiers

ISSN

1757-4676,1757-4684

E-ISSN

1757-4684

DOI

10.15252/emmm.201809712

How to access this item